513 related articles for article (PubMed ID: 32067967)
1. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
2. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
3. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
4. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
6. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
7. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
8. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
9. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
10. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
Collins E; Strandell A; Granåsen G; Idahl A
Am J Obstet Gynecol; 2019 Jan; 220(1):85.e1-85.e10. PubMed ID: 30321526
[TBL] [Abstract][Full Text] [Related]
11. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.
Rufin KGA; do Valle HA; McAlpine JN; Elwood C; Hanley GE
Fertil Steril; 2024 Mar; 121(3):531-539. PubMed ID: 38043843
[TBL] [Abstract][Full Text] [Related]
12. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
[TBL] [Abstract][Full Text] [Related]
15. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
16. STop OVarian CAncer (STOPOVCA) young: Protocol for a multicenter follow-up study to determine the long-term effects of opportunistic salpingectomy on age at menopause.
Gelderblom ME; IntHout J; Hermens RPMG; Coppus SFPJ; Ebisch I; van Ginkel AA; van de Laar R; de Lange N; Maassen M; Pijlman B; Smedts HPM; Vos MC; Beerendonk CCM; de Hullu JA; Piek JMJ
Maturitas; 2022 May; 159():62-68. PubMed ID: 35337614
[TBL] [Abstract][Full Text] [Related]
17. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
Hanley GE; Pearce CL; Talhouk A; Kwon JS; Finlayson SJ; McAlpine JN; Huntsman DG; Miller D
JAMA Netw Open; 2022 Feb; 5(2):e2147343. PubMed ID: 35138400
[TBL] [Abstract][Full Text] [Related]
18. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status.
Long AJ; Kaur P; Lukey A; Allaire C; Kwon JS; Talhouk A; Yong PJ; Hanley GE
Am J Obstet Gynecol; 2023 Jan; 228(1):57.e1-57.e18. PubMed ID: 36029832
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
